Cancer therapy targeting the fibrinolytic system.
Heissig B, Eiamboonsert S, Salama Y, Shimazu H, Dhahri D, Munakata S, Tashiro Y, Hattori K.
Heissig B, et al. Among authors: hattori k.
Adv Drug Deliv Rev. 2016 Apr 1;99(Pt B):172-179. doi: 10.1016/j.addr.2015.11.010. Epub 2015 Nov 14.
Adv Drug Deliv Rev. 2016.
PMID: 26588878
Review.